β-Lapachone-induced apoptosis in human prostate cancer cells: Involvement of NQO1/xip3

Experimental Cell Research

Volumn 267, Issue 1, 2001, Pages 95-106

  Planchon, Sarah M ^a   Pink, John J ^a   Tagliarino, Colleen ^a   Bornmann, William G ^b   Varnes, Marie E ^a   Boothman, David A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Apoptosis; Atypical PARP cleavage; NQO1; P53 cleavage; Prostate cancer; X ray inducible protein 3 (xip3); lapachone

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BETA LAPACHONE; DICOUMAROL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME DEGRADATION; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0035398693     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5234     Document Type: Article

References (63)

1. Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: A p53-independent response
2. Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I
3. Induction of apoptosis in MCF-7-WS8 breast cancer cells by beta-lapachone
4. Induction of apoptosis by beta-lapachone in human prostate cancer cells
5. Beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin
6. Induction of DNA topoisomerase II-mediated DNA cleavage by beta-lapachone and related naphthoquinones
7. Suppression of tumor necrosis factor-activated nuclear transcription factor-kappaB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone
8. NAD(P)H:quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity
9. NAD(P)H:quinone oxidoreductasel (DT-diaphorase): Expression, regulation, and role in cancer
10. Isolation of X-ray-inducible transcripts from radioresistant human melanoma cells
11. Enzymatic and molecular aspects of the antioxidant effect of menadione in hepatic microsomes
12. NAD(P)H: Quinone oxidoreductasel (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase
13. DT-diaphorase in activation and detoxification of quinones: Bioreductive activation of mitomycin C
14. DT-diaphorase: Redox potential, steady-state, and rapid reaction studies
15. Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9
16. Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies
17. NAD(P)H: Quinon oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues
18. DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours
19. DT-diaphorase: Possible roles in cancer chemotherapy and carcinogenesis
20. Bcl-2 protects against beta-lapachone-mediated caspase 3 activation and apoptosis in human myeloid leukemia (HL-60) cells
21. Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes
22. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents
23. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle
24. Selective cleavage of nuclear autoantigens during Cd95 (Fas/Apo-1)-mediated T cell apoptosis
25. Transducing signals of life and death
26. Substrate specificities of caspase family proteases
27. The role of the caspase family of cysteine proteases in apoptosis
28. Death substrates come alive
29. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation
30. Caspase-dependent activation of calpain during drug-induced apoptosis
31. Calpain and calpastatin regulate neutrophil apoptosis
32. Calpain activation in apoptosis
33. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
34. Activation of the Cpp32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents
35. Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during beta-lapachone-mediated apoptosis
36. Isolation of a human prostate carcinoma cell line (DU 145)
37. Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice
38. LNCaP model of human prostatic carcinoma
39. Expression of human NAD(P)H:quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: Effect on the toxicity of antitumor quinones
40. DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water
41. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors
42. Reductase enzyme expression across the National Cancer Institute tumor cell line panel: Correlation with sensitivity to mitomycin C and EO9
43. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes: A study of the implications of oxidative stress in intact cells
44. Studies on the reaction mechanism of DT diaphorase: Intermediary plateau and trough regions in the initial velocity vs substrate concentration curves
45. Purification and properties of NADPH-cytochrome P-450 reductase
46. A note on the inhibition of DT-diaphorase by dicoumarol
47. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents
48. Lamin proteolysis facilitates nuclear events during apoptosis
49. Two different proteases are involved in the proteolysis of lamin during apoptosis
50. Substrate and inhibitor specificity of interleukin-1 beta-converting enzyme and related caspases
51. Calcium dependence of glucocorticoid-induced lymphocytolysis
52. Effect of glucocorticosteroid treatment on intracellular calcium homeostasis in mouse lymphoma cells
53. Calpain, an upstream regulator of thymocyte apoptosis
54. Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: Contributory roles of both protease families in neuronal apoptosis
55. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis
56. Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells
57. TUNEL staining of inner ear structures may reflect autolysis, not apoptosis
58. Inhibition of radiation-induced neoplastic transformation by beta-lapachone
59. 2H-naphtho[1,2-b]pyran-5,6-dione), a novel DNA repair inhibitor
60. Inhibition of radiation-induced neoplastic transformation by beta-lapachone
61. The levels of quinone reductases, superoxide dismutase and glutathione-related enzymatic activities in diethylstilbestrol-induced carcinogenesis in the kidney of male Syrian golden hamsters
62. Comparison of hepatic carcinogen initiation-promotion systems